NCT06392139

Brief Summary

A quasi-experimental pragmatic trial was developed to evaluate a specific health-care service for the treatment of biporal personality disorder (BPD) patients.The effectiveness and economic evaluation (cost-effectiveness and cost-utility) of this specific health-care service as it is offered in every-day clinical practice will be assesed. The main hypothesis of the particular study is that the specific health-care service for the treatment of BPD patients has better efficacy and cost-effectiveness than the treatment as usual. Furthermore, two additional substudies will be performed. The first one is a qualitative study on the experiences of patients and therapists of the specific program as compared to common treatment. The second substudy aims to investigate the effectiveness and the possible psychodynamic functions of the initial outpatient reception clinic of the specific program. Patients will be followed for 2 years.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jan 2022Jun 2026

Study Start

First participant enrolled

January 7, 2022

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 30, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

2.4 years

First QC Date

March 6, 2024

Last Update Submit

April 26, 2024

Conditions

Keywords

Borderline Personality Disorder

Outcome Measures

Primary Outcomes (2)

  • Severity of BPD and severe parasuicidal behavior as defined by Bateman and Fonagy (2009).

    It is assessed using the Borderline Personality Disorder Severity Index (BPDSI) and the latter is assessed through the number of 1) suicide attempts, 2) life-threatening self-harm behaviors and 3) psychiatric hospital admissions.

    Baseline, 6 months, 1 year, 18 months, 2 years

  • Suicide Harm Inventory

    It is an interview designed to ensure accurate collection of data about attempted acts of suicide and incidents of self-harm over a six-month period but does not aim to measure their severity.

    Baseline, 6 months, 1 year, 18 months, 2 years

Secondary Outcomes (10)

  • General psychiatric symptoms present at the time of assessment.

    Baseline, 6 months, 1 year, 18 months, 2 years

  • Subjective Quality of Life

    Baseline, 6 months, 1 year, 18 months, 2 years

  • Distress caused by interpersonal problems

    Baseline, 6 months, 1 year, 18 months, 2 years

  • Functional Impairments in fields such as work and household

    Baseline, 6 months, 1 year, 18 months, 2 years

  • WHODAS II

    Baseline, 6 months, 2 years

  • +5 more secondary outcomes

Other Outcomes (3)

  • Cost-Effectiveness

    Baseline, 6 months, 1 year, 18 months, 2 years

  • ALL 3 MECHANISMS OF CHANGE- RFQ, IPO-GR, DSQ-40

    Baseline, 1 year, 2 years

  • ETI - Early Trauma Inventory

    Baseline, 2 years

Study Arms (2)

Experimental: Intervention group

EXPERIMENTAL

The Specific Therapy Program for Personality Disorders at the 1st Psychiatric Clinic, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, established in 1999, offers outpatient, inpatient, and day care services with psychoanalytic interventions tailored for Borderline Personality Disorder. Group psychoanalytic psychotherapy sessions are predominant, supported by research. Patients undergo initial 6-8 months of closely monitored outpatient care, including monthly psychodynamically oriented sessions, psychiatric appointments, and psychological assessments, focusing on crisis management and personalized treatment plans. Subsequently, long-term psychodynamic psychotherapy interventions, often combined with psychiatric treatment, provide sustained therapeutic support.

Behavioral: Specific Therapy Program for Personality Disorders

Treatment As Usual (TAU) Group

ACTIVE COMPARATOR

The TAU group receives the common practice treatment in the two Specific Outpatient Clinics for BPD patients: 1. The Outpatient Clinic for Borderline Personality Disorder Patients of the 2nd Psychiatric Clinic at the Medical School of National and Kapodistrian University of Athens called Attikon General University Hospital and 2. The Outpatient Clinic for Borderline Personality Disorder Patients of the Psychiatric Clinic of Sismanogleion General Hospital.

Other: Treatment As Usual (TAU) Group

Interventions

The program was founded in 1999; since then, it has provided a wide range of different treatment interventions (outpatient, inpatient and day care). The interventions are psychoanalytically oriented and specifically for patients with Borderline Personality Disorder. Most of them are in the form of group psychoanalytic psychotherapy. The program consists of two steps: 1) an initial reception outpatient clinic where patients are followed after the referral to the Program, for a period of 6-8 months. This first step consists of monthly psychodynamically oriented sessions, monthly psychiatric appointments and application of psychological assessment instruments. The intervention focuses on crisis management and construction of the treatment plan for every patient. 2) The second step consists of long-term psychodynamic psychotherapy interventions, in combination with psychiatric treatment when it is is needed.

Also known as: BPDAS
Experimental: Intervention group

The TAU group receives the common practice treatment in the two Specific Outpatient Clinics for BPD patients: The Outpatient Clinic for Borderline Personality Disorder Patients of the 2nd Psychiatric Clinic at the Medical School of National and Kapodistrian University of Athens called Attikon General University Hospital and The Outpatient Clinic for Borderline Personality Disorder Patients of the Psychiatric Clinic of Sismanogleion General Hospital. Treatment As Usual (TAU) The TAU includes the psychiatric management, consultation and pharmacotherapy if needed in the two Specific Outpatient Clinics for BPD patients. TAU provides one thirty minutes session per month. In case of crisis management patients contact their psychiatrist during the working hours, or after that they leave a message on the telephone answering machine and if needed make a visit in the Emergency Department of the Hospital on Duty.

Treatment As Usual (TAU) Group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • primary diagnosis of BPD (diagnosed with Structural Clinical Interview for DSM-5 Personality Disorders; SCID-5-PD and
  • willingness to participate in the study.

You may not qualify if:

  • lifetime psychotic disorder (except for a brief psychotic disorder as described in the Diagnostic and Statistical Manual of Mental Disorders, version V, DSM-5, BPD criterion 9,
  • bipolar disorder type I,
  • antisocial personality disorder,
  • severe substance dependence resulting in severe cognitive restrictions during therapy, needing clinical detoxification,
  • IQ below 80,
  • organic brain disease,
  • poor Greek language skills.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

1st Psychiatric Clinic, Medical School, National Kapodistrian University of Athens, Eginition Hospital

Athens, Attica, 11528, Greece

RECRUITING

Outpatient Clinic for Borderline Personality Disorder Patients, 2nd Psychiatric Clinic, Medical School of National Kapodistrian University of Athens: Attikon General University Hospital

Athens, Attica, 12462, Greece

RECRUITING

Outpatient Clinic for Borderline Personality Disorder Patients, Psychiatric Clinic of Sismanogleion General Hospital

Athens, Attica, 15126, Greece

RECRUITING

Related Publications (22)

  • National Collaborating Centre for Mental Health (UK). Borderline Personality Disorder: Treatment and Management. Leicester (UK): British Psychological Society (UK); 2009. Available from http://www.ncbi.nlm.nih.gov/books/NBK55403/

    PMID: 21796831BACKGROUND
  • Vaslamatzis G, Coccossis M, Zervis C, Panagiotopoulou V, Chatziandreou M. A psychoanalytically oriented combined treatment approach for severely disturbed borderline patients: the Athens project. Bull Menninger Clin. 2004 Fall;68(4):337-49. doi: 10.1521/bumc.68.4.337.56640.

    PMID: 15843180BACKGROUND
  • Vaslamatzis G, Theodoropoulos P, Vondikaki S, Karamanolaki H, MiliaTsanira M, Gourounti K. Is the residential combined (psychotherapy plus medication) treatment of patients with severe personality disorder effective in terms of suicidality and impulsivity? J Nerv Ment Dis. 2014 Feb;202(2):138-43. doi: 10.1097/NMD.0000000000000083.

    PMID: 24469526BACKGROUND
  • E. Layiou-Lignos, L. Anagnostaki, I. Malogiannis & H. Karamanolaki (2021): The psychoanalytic psychotherapy endeavor in the Greek public sector, Psychoanalytic Psychotherapy, DOI: 10.1080/02668734.2021.1898045

    BACKGROUND
  • Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry. 2009 Dec;166(12):1355-64. doi: 10.1176/appi.ajp.2009.09040539. Epub 2009 Oct 15.

    PMID: 19833787BACKGROUND
  • Leibniz Institute for Psychology (ZPID). (2019). Open Test Archive: BPDSI-IV. Borderline Personality Disorder Severity Index (Version IV) - deutsche Fassung. Available at: https://www.testarchiv.eu/en/test/9007150κ

    BACKGROUND
  • Bateman, A., Fonagy, P. (2004) Suicide and self-harm inventory. In: Psychotherapy for Borderline Personality Disorder: Mentalization-based treatment. New York, NY: Oxford University Press.

    BACKGROUND
  • Derogatis, L. R. (1993). BSI brief symptom inventory: Administration, scoring, and procedures manual (4th ed.). Minneapolis, MN: National Computer Systems.

    BACKGROUND
  • Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998 May;28(3):551-8. doi: 10.1017/s0033291798006667.

    PMID: 9626712BACKGROUND
  • Horowitz, L. M., Alden, L., Wiggins, J., & Pincus, A. (2000). Inventory of Interpersonal Problems Manual. San Antonio, TX: The Psychological Corporation.

    BACKGROUND
  • Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002 May;180:461-4. doi: 10.1192/bjp.180.5.461.

    PMID: 11983645BACKGROUND
  • Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M, Pull C; WHO/NIH Joint Project. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010 Nov 1;88(11):815-23. doi: 10.2471/BLT.09.067231. Epub 2010 May 20.

    PMID: 21076562BACKGROUND
  • Fonagy P, Luyten P, Moulton-Perkins A, Lee YW, Warren F, Howard S, Ghinai R, Fearon P, Lowyck B. Development and Validation of a Self-Report Measure of Mentalizing: The Reflective Functioning Questionnaire. PLoS One. 2016 Jul 8;11(7):e0158678. doi: 10.1371/journal.pone.0158678. eCollection 2016.

    PMID: 27392018BACKGROUND
  • Andrews G, Singh M, Bond M. The Defense Style Questionnaire. J Nerv Ment Dis. 1993 Apr;181(4):246-56. doi: 10.1097/00005053-199304000-00006.

    PMID: 8473876BACKGROUND
  • Lenzenweger MF, Clarkin JF, Kernberg OF, Foelsch PA. The Inventory of Personality Organization: psychometric properties, factorial composition, and criterion relations with affect, aggressive dyscontrol, psychosis proneness, and self-domains in a nonclinical sample. Psychol Assess. 2001 Dec;13(4):577-91.

    PMID: 11793901BACKGROUND
  • Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207. doi: 10.1016/0149-7189(79)90094-6. No abstract available.

    PMID: 10245370BACKGROUND
  • Brooks R. EuroQol: the current state of play. Health Policy. 1996 Jul;37(1):53-72. doi: 10.1016/0168-8510(96)00822-6.

    PMID: 10158943BACKGROUND
  • Wetzelaer P, Farrell J, Evers SM, Jacob GA, Lee CW, Brand O, van Breukelen G, Fassbinder E, Fretwell H, Harper RP, Lavender A, Lockwood G, Malogiannis IA, Schweiger U, Startup H, Stevenson T, Zarbock G, Arntz A. Design of an international multicentre RCT on group schema therapy for borderline personality disorder. BMC Psychiatry. 2014 Nov 18;14:319. doi: 10.1186/s12888-014-0319-3.

    PMID: 25407009BACKGROUND
  • Bremner JD, Bolus R, Mayer EA. Psychometric properties of the Early Trauma Inventory-Self Report. J Nerv Ment Dis. 2007 Mar;195(3):211-8. doi: 10.1097/01.nmd.0000243824.84651.6c.

    PMID: 17468680BACKGROUND
  • First MB, Williams JBW, Benjamin LS, Spitzer RL: User's Guide for the SCID-5-PD (Structured Clinical Interview for DSM-5 Personality Disorder). Arlington, VA, American Psychiatric Association, 2015

    BACKGROUND
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596

    BACKGROUND
  • Malogiannis I, Anagnostaki L, Aspradaki M, Aristotelidis P, Karambela K, Amperiadou M, Efthymiou V, Kriezi P, Theodoridou I, Stefanatou P, Konstantakopoulos G, Souliotis K, Peppou LE, Giannoulis E. Borderline personality disorder Athens study: a quasi-experimental pragmatic trial for the assessment of a public, psychodynamic, stepped care service for borderline personality disorder patients. Front Psychiatry. 2025 Jul 1;16:1493265. doi: 10.3389/fpsyt.2025.1493265. eCollection 2025.

MeSH Terms

Conditions

Borderline Personality Disorder

Interventions

TherapeuticsPopulation Groups

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Intervention Hierarchy (Ancestors)

DemographyPopulation Characteristics

Central Study Contacts

Ioannis A. Malogiannis, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Mr Ioannis A. Malogiannis, Head of the BPD Specific Sector

Study Record Dates

First Submitted

March 6, 2024

First Posted

April 30, 2024

Study Start

January 7, 2022

Primary Completion

June 1, 2024

Study Completion (Estimated)

June 1, 2026

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations